The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis
Salvatore Facciorusso(Humanitas University), Andrea Santamato(University of Foggia), Gerard E. Francisco(Memorial Hermann Institute for Rehabilitation and Research Foundation), Alessio Baricich(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Stefania Spina(University of Foggia), Alessandro Picelli(University of Verona), Franco Molteni(Bambino Gesù Children's Hospital), Jörg Wissel(University of Potsdam)
Cited by 26
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport
|Journal of Neurology Neurosurgery & Psychiatry|1998|219
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168